![]() |
Name |
2-Octene
|
Molecular Formula | C8H16 | |
IUPAC Name* |
(E)-oct-2-ene
|
|
SMILES |
CCCCC/C=C/C
|
|
InChI |
InChI=1S/C8H16/c1-3-5-7-8-6-4-2/h3,5H,4,6-8H2,1-2H3/b5-3+
|
|
InChIKey |
ILPBINAXDRFYPL-HWKANZROSA-N
|
|
Synonyms |
trans-2-Octene; 2-OCTENE; 13389-42-9; (E)-2-Octene; (E)-oct-2-ene; 2-Octene, (2E)-; 2-Octene, (E)-; OCTENE-2; (2E)-2-Octene; G13G1YR8YW; 111-67-1; trans-Oct-2-ene; UNII-G13G1YR8YW; MFCD00009532; NSC-97522; NSC-244460; EINECS 203-894-2; EINECS 236-463-2; NSC 66572; Z-2-Octene; (2E)-oct-2-ene; trans-2-Octene, 97%; 2-OCTENE, TRANS-; CHEBI:88820; DTXSID30872994; 2-Octene, cis + trans, 98%; CHEBI:167529; ZINC1693961; NSC 97522; NSC244460; LS-13494; O0132; Q24735790
|
|
CAS | 13389-42-9 | |
PubChem CID | 5364448 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 112.21 | ALogp: | 3.7 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 8 | QED Weighted: | 0.382 |
Caco-2 Permeability: | -4.278 | MDCK Permeability: | 0.00001840 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.401 |
30% Bioavailability (F30%): | 0.929 |
Blood-Brain-Barrier Penetration (BBB): | 0.956 | Plasma Protein Binding (PPB): | 97.95% |
Volume Distribution (VD): | 5.789 | Fu: | 3.63% |
CYP1A2-inhibitor: | 0.959 | CYP1A2-substrate: | 0.76 |
CYP2C19-inhibitor: | 0.433 | CYP2C19-substrate: | 0.543 |
CYP2C9-inhibitor: | 0.2 | CYP2C9-substrate: | 0.906 |
CYP2D6-inhibitor: | 0.163 | CYP2D6-substrate: | 0.412 |
CYP3A4-inhibitor: | 0.049 | CYP3A4-substrate: | 0.139 |
Clearance (CL): | 6.295 | Half-life (T1/2): | 0.435 |
hERG Blockers: | 0.016 | Human Hepatotoxicity (H-HT): | 0.031 |
Drug-inuced Liver Injury (DILI): | 0.04 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.016 | Maximum Recommended Daily Dose: | 0.137 |
Skin Sensitization: | 0.852 | Carcinogencity: | 0.05 |
Eye Corrosion: | 0.992 | Eye Irritation: | 0.987 |
Respiratory Toxicity: | 0.215 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001684 | ![]() |
0.710 | D01QLH | ![]() |
0.333 | ||
ENC001656 | ![]() |
0.595 | D0UE9X | ![]() |
0.274 | ||
ENC001255 | ![]() |
0.567 | D0O1TC | ![]() |
0.250 | ||
ENC001597 | ![]() |
0.567 | D0O1PH | ![]() |
0.239 | ||
ENC001644 | ![]() |
0.550 | D0N3NO | ![]() |
0.215 | ||
ENC001668 | ![]() |
0.529 | D06FEA | ![]() |
0.213 | ||
ENC001598 | ![]() |
0.515 | D0OR6A | ![]() |
0.212 | ||
ENC001696 | ![]() |
0.486 | D0AY9Q | ![]() |
0.208 | ||
ENC001693 | ![]() |
0.474 | D08SJZ | ![]() |
0.207 | ||
ENC004479 | ![]() |
0.472 | D0U5CE | ![]() |
0.203 |